Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 586 AL 600

Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis

Bagyinszky E, Giau VV, Shim K, Suk K, An SSA, Kim S.

J Neurol Sci. 2017 May 15;376:242-254. doi: 10.1016/j.jns.2017.03.031. Epub 2017 Mar 22.

Dependency criterion based brain pathological age estimation of Alzheimer's disease patients with MR scans

Li Y, Liu Y, Wang P, Wang J, Xu S, Qiu M; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Biomed Eng Online. 2017 Apr 24;16(1):50. doi: 10.1186/s12938-017-0342-y.

Regulatory effects of galanin system on development of several age-related chronic diseases

Fang P, Yu M, Wan D, Zhang L, Han L, Shen Z, Shi M, Zhu Y, Zhang Z, Bo P.

Exp Gerontol. 2017 Sep;95:88-97. doi: 10.1016/j.exger.2017.04.009. Epub 2017 Apr 25.

Reversible Pisa Syndrome Induced by Rivastigmine in a Patient With Early-Onset Alzheimer Disease

Hsu CW, Lee Y, Lee CY, Lin PY.

Clin Neuropharmacol. 2017 May/Jun;40(3):147-148. doi: 10.1097/WNF.0000000000000215.

The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer's Disease (PDC-dAD): Gauging their Validity over a Decade Later

Sepehry AA, Lee PE, Hsiung GR, Beattie BL, Feldman HH, Jacova C.

J Alzheimers Dis. 2017;58(2):449-462. doi: 10.3233/JAD-161061.

Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles

Sadiq D, Whitfield T, Lee L, Stevens T, Costafreda S, Walker Z.

J Alzheimers Dis. 2017;58(2):463-470. doi: 10.3233/JAD-161089.

Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?

Sun J, Zhou H, Bai F, Zhang Z, Ren Q.

J Alzheimers Dis. 2017;58(3):597-612. doi: 10.3233/JAD-170036.

Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease

Lam AD, Deck G, Goldman A, Eskandar EN, Noebels J, Cole AJ.

Nat Med. 2017 Jun;23(6):678-680. doi: 10.1038/nm.4330. Epub 2017 May 1.

Comorbidity and progression of late onset Alzheimer's disease: A systematic review

Haaksma ML, Vilela LR, Marengoni A, Calderón-Larrañaga A, Leoutsakos JS, Olde Rikkert MGM, Melis RJF.

PLoS One. 2017 May 4;12(5):e0177044. doi: 10.1371/journal.pone.0177044. eCollection 2017.

Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging

Cerami C, Iaccarino L, Perani D.

Int J Mol Sci. 2017 May 5;18(5):993. doi: 10.3390/ijms18050993.

Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective

Ahmad J, Akhter S, Rizwanullah M, Khan MA, Pigeon L, Addo RT, Greig NH, Midoux P, Pichon C, Kamal MA.

Curr Alzheimer Res. 2017;14(11):1164-1181. doi: 10.2174/1567205014666170508121031.

Impact of multiple pathologies on the threshold for clinically overt dementia

Kapasi A, DeCarli C, Schneider JA.

Acta Neuropathol. 2017 Aug;134(2):171-186. doi: 10.1007/s00401-017-1717-7. Epub 2017 May 9.

Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis

Orgeta V, Tabet N, Nilforooshan R, Howard R.

J Alzheimers Dis. 2017;58(3):725-733. doi: 10.3233/JAD-161247.

State of Play in Alzheimer's Disease Genetics

Zhu JB, Tan CC, Tan L, Yu JT.

J Alzheimers Dis. 2017;58(3):631-659. doi: 10.3233/JAD-170062.

Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease

Musaeus CS, Shafi MM, Santarnecchi E, Herman ST, Press DZ.

J Alzheimers Dis. 2017;58(4):1065-1076. doi: 10.3233/JAD-160742.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias